Bubshait Dalal K, Himdy Ziyad E, Fadaaq Ola, Alshmas Hajar I
Pediatrics, King Fahd University Hospital, Al-Khobar, SAU.
Pediatrics, Imam Abdulrahman Bin Faisal University, Dammam, SAU.
Cureus. 2020 Jan 21;12(1):e6725. doi: 10.7759/cureus.6725.
Osteopetrosis is a rare genetic disease of bone resorption. It includes a variety of hereditary skeletal disorders that have the main radiographic feature of increased bone density and thickness due to differentiation or functional defects in osteoclast. The clinical presentation varies widely based on the type of osteopetrosis and ranges in severity from asymptomatic to a fatal course. Our case is of the infantile malignant osteopetrosis (IMOP) form. It is inherited as an autosomal recessive pattern that generally starts in intrauterine life and manifests at birth or early childhood. It is the most severe form and has an incidence of 1 in 250,000 births. The patient presented at the age of two months with a history of recurrent fever, recurrent pneumonia, developmental delay, and infantile spasms. Upon examination, she was found to have hepatosplenomegaly, axial hypotonia, limb spasticity, and visual impairment. Genetic testing revealed a homozygous variant of OSTM1 gene, which is a known Saudi mutation of autosomal recessive osteopetrosis (ARO). IMOP should be considered as a rare differential of hepatosplenomegaly. Early diagnosis by clinical picture, imaging, and genetic testing is important to direct the appropriate management in order to prevent disease progression before the irreversible neurological sequelae occur. Patients should be managed by a comprehensive approach, and currently, hematopoietic stem cell transplantation (HSCT) provides a better outcome for IMOP patients.
骨质石化症是一种罕见的骨吸收遗传性疾病。它包括多种遗传性骨骼疾病,其主要影像学特征是由于破骨细胞分化或功能缺陷导致骨密度和厚度增加。临床表现因骨质石化症的类型而异,严重程度从无症状到致命病程不等。我们的病例属于婴儿恶性骨质石化症(IMOP)类型。它以常染色体隐性模式遗传,通常始于子宫内生活,并在出生时或幼儿期表现出来。它是最严重的形式,在每25万例出生中发生率为1例。该患者在两个月大时出现反复发热、反复肺炎、发育迟缓及婴儿痉挛病史。经检查,发现她有肝脾肿大、轴向肌张力减退、肢体痉挛和视力障碍。基因检测显示OSTM1基因存在纯合变异,这是一种已知的沙特常染色体隐性骨质石化症(ARO)突变。IMOP应被视为肝脾肿大的一种罕见鉴别诊断。通过临床表现、影像学和基因检测进行早期诊断对于指导适当的治疗很重要,以便在不可逆的神经后遗症出现之前预防疾病进展。患者应采用综合方法进行治疗,目前,造血干细胞移植(HSCT)为IMOP患者提供了更好的治疗效果。